Anelechi Anyanwu, MD, is Professor and Vice Chair of the Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai. He is also the Surgical Director for Heart Transplantation and Mechanical Circulatory Support at the Mount Sinai Health System.
Dr. Anyanwu was trained intensively in the entire spectrum of techniques for mitral valve repair, and is one of only a handful of surgeons in the United States to received formal training in mitral valve repair to a proficient and advanced level. His main interests are in minimally invasive mitral valve repair and mitral valve repair for dilated cardiomyopathies. Apart from mitral repair, Dr. Anyanwu is an expert in complex re-operative valvular surgery, and heart failure surgery. Dr. Anyanwu has led the advanced heart failure program, introducing new mechanical devices for circulatory support and has also re-established the combined heart-lung transplant program.
He trained in Cardiothoracic Surgery at the Harefield Hospital, London, United Kingdom and affiliated hospitals in the University of London Network. He was trained by internationally renowned surgeons including Professor Sir Magdi Yacoub, Professor Gilles Dreyfus and Professor Tom Treasure. Under the tutelage of Professor Yacoub and Dr. Ashgar Khaghani, he was trained in Heart and Lung Transplantation. Harefield Hospital has performed more thoracic organ transplants than any other hospital in the world — Dr. Anyanwu is one of few surgeons world-wide who are trained in all aspects of thoracic transplantation including heart transplantation, heterotopic heart transplantation, heart-lung transplantation, domino heart transplantation and lung transplantation. At Harefield hospital he was also trained in various aspects of heart valve surgery including homograft implantation, another field pioneered by Professor Yacoub’s team. His other areas of specialized training include multiple arterial revascularization using bilateral skeletonized internal mammary artery grafts — this operation is more durable than the standard coronary artery bypass surgery using a single mammary artery and leg veins for bypass. Using the technique of skeletonization, bilateral internal mammary artery grafting can be extended to most patients even diabetic and obese patients (who are generally excluded from multiple arterial grafts).
Dr. Anyanwu also has an interest in minimally invasive surgery and received training in this area in London. His interests include reducing invasiveness of surgery by minimizing incisions and tissue dissection, avoiding cardiopulmonary bypass or myocardial ischemia and reducing level of anesthesia and monitoring. He has performed open heart surgery on awake patients with use of epidural anesthesia, a technique that may hasten patient recovery and reduce morbidity in selected patients.
Following his training in England, Dr. Anyanwu joined the Department of Cardiovascular Surgery at The Mount Sinai Medical Center in 2004 as a Senior Clinical Fellow. His primary interests were Mitral Valve Repair, Complex Valvular surgery, Surgery for Heart Failure and Re-operative Cardiac Surgery.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Anyanwu has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Rosemarie P. New Jersey
I will be 80 years old in June thanks to you and your team. ”Read Story
Mitral valve repair for severe mitral valve regurgitation during left ventricular assist device implantation.Amit Pawale, MD, Shinobu Itagaki, MD, Aditya Parikh, MD, Sean P. Pinney, MD, David H.Adams, MD, Anelechi C. Anyanwu, MD
- Adam S. Evans, MD, Matthew A. Levin, MD, Hung-Mo Lin, ScD, Ken Lee, BS, Menachem M. Weiner, MD, Anelechi Anyanwu, MD, David H. Adams, MD, Alexander J.C. Mittnacht, MD
Assessment of longitudinal myocardial mechanics in patients with degenerative mitral valve regurgitation predicts postoperative worsening of left ventricular systolic function.Dimosthenis Pandis, MD, Partho P. Sengupta, MD, Javier Castillo, MD, Guiseppe Caracciolo, MD, PhD, Gregory W. Fischer, MD, Jagat Narula, MD, PhD, Anelechi C. Anyanwu, MD, and David H. Adams, MD
Re-repair of the mitral valve as a primary strategy for early and late failures of mitral valve repair.Anelechi C. Anyanwu, MD, Shinobu Itagaki, MD, Robin Varghese, MD, Javier Castillo, MD, Joanna Chikwe, MD and David H. Adams, MD